Apyx Medical
APYX
Apyx Medical (APYX) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.07
- EPS estimate
- −$0.08
- EPS surprise
- +14.63%
- Revenue surprise
- +5.38%
- Revenue
- $13.9M
- Revenue estimate
- $13.2M
- Reported
- Aug 6, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 6, 2026 | −$0.08 | −$0.07 | +14.63% | $13.9M | SEC |
| Q1 2026 | May 7, 2026 | −$0.11 | −$0.05 | +54.55% | $12.5M | SEC |
| Q4 2025 | Mar 10, 2026 | −$0.06 | −$0.03 | +45.45% | $19.2M | SEC |
| Q3 2025 | Nov 6, 2025 | −$0.10 | −$0.05 | +51.17% | $12.9M | SEC |
| Q2 2025 | Aug 7, 2025 | −$0.09 | −$0.09 | +3.54% | $11.4M | SEC |
| Q1 2025 | May 8, 2025 | −$0.12 | −$0.10 | +16.67% | $9.4M | SEC |
| Q4 2024 | Mar 13, 2025 | −$0.16 | −$0.12 | +24.81% | $14.2M | SEC |
| Q3 2024 | Nov 8, 2024 | −$0.18 | −$0.14 | +23.91% | $11.5M | SEC |
| Q2 2024 | Aug 8, 2024 | −$0.20 | −$0.19 | +4.04% | $12.1M | SEC |
| Q1 2024 | May 9, 2024 | −$0.22 | −$0.22 | −1.85% | $10.2M | SEC |
| Q4 2023 | Mar 21, 2024 | −$0.18 | −$0.28 | −57.30% | $14.7M | SEC |
| Q3 2023 | Nov 9, 2023 | −$0.11 | −$0.13 | −14.04% | $12.0M | SEC |
| Q2 2023 | Aug 10, 2023 | −$0.07 | −$0.03 | +57.14% | $13.6M | SEC |
| Q1 2023 | May 11, 2023 | −$0.14 | −$0.10 | +25.93% | $12.1M | SEC |
| Q4 2022 | Mar 16, 2023 | −$0.14 | −$0.17 | −19.30% | $12.6M | SEC |
| Q3 2022 | Nov 10, 2022 | −$0.15 | −$0.17 | −17.24% | $9.1M | SEC |
| Q2 2022 | Aug 11, 2022 | −$0.19 | −$0.16 | +14.67% | $10.3M | SEC |
| Q1 2022 | May 12, 2022 | −$0.15 | −$0.17 | −15.88% | $12.5M | SEC |
| Q4 2021 | Mar 17, 2022 | −$0.11 | −$0.06 | +45.45% | $16.8M | SEC |
| Q3 2021 | Nov 12, 2021 | −$0.15 | −$0.12 | +20.00% | $11.8M | SEC |
Quarterly revenue
Frequently asked questions
When did Apyx Medical (APYX) last report earnings?
Apyx Medical last reported on Aug 6, 2026, covering fiscal Q2 2026.
Did APYX beat earnings estimates?
Yes. Apyx Medical reported EPS of −$0.07 for Q2 2026 against a −$0.08 estimate — a 14.63% beat.
How much revenue did APYX report last quarter?
Apyx Medical reported $13.9M in revenue for Q2 2026, against a consensus estimate of $13.2M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.